The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
South West; Gloucestershire; Wiltshire and North Somerset
Location of affected unit(s)
Swindon
Sector
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21.1 - Manufacture of basic pharmaceutical products
100 jobs Number of planned job creations
Announcement Date
26 September 2019
Employment effect (start)
26 September 2019
Foreseen end date
Description
Catalent, a US-owned pharmaceutical company, has announced plans to create 100 new jobs as it expands its site in Swindon. The jobs will be supported by an investment of GBP 27 million (€31 million as at 6 October 2019), which will introduce new technology to increase production capacity. The business specialises in manufacturing tablets, which can be taken without the aid of water and does pharmaceutical testing for other UK and international companies.
Eurofound (2019), Catalent, Business expansion in United Kingdom, factsheet number 98951, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/98951.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
